Stay updated on FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial
Sign up to get notified when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.

Latest updates to the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. No visible changes to study details or page behavior.SummaryDifference0.0%

- Check17 days agoChange DetectedNo substantive changes detected in the provided screenshots; the page content appears unchanged.SummaryDifference0.0%

- Check31 days agoChange DetectedGastric cancer is now listed as a related topic and the Genetic and Rare Diseases Information Center resources have been added; the revision label was updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check39 days agoChange DetectedThe change is a minor revision update: Revision: v3.4.1 added and v3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedMinor UI and metadata updates were applied: a glossary toggle is now available ('Show glossary'), a QC-related label 'Last Update Submitted that Met QC Criteria' was added, FEAR Act wording capitalization changed, and the page revision updated to 'Revision: v3.4.0' while older variants were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; there are no changes to core content, study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.